WHO Expert Committee on Specifications for Pharmaceutical Preparations : thirty-seventh report.
Saved in:
Superior document: | WHO technical report series, 908 |
---|---|
: | |
TeilnehmendeR: | |
Year of Publication: | 2003 |
Language: | English |
Series: | Technical report series (World Health Organization) ;
908. |
Online Access: | |
Physical Description: | viii, 145 p. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02807nam a2200349Ia 4500 | ||
---|---|---|---|
001 | 500284793 | ||
003 | MiAaPQ | ||
005 | 20200520144314.0 | ||
006 | m o d | | ||
007 | cr cn||||||||| | ||
008 | 030508s2003 sz s o000 0 eng d | ||
020 | |z 9241209089 | ||
035 | |a (MiAaPQ)500284793 | ||
035 | |a (Au-PeEL)EBL284793 | ||
035 | |a (CaPaEBR)ebr10040297 | ||
035 | |a (OCoLC)191039475 | ||
040 | |a MiAaPQ |c MiAaPQ |d MiAaPQ | ||
050 | 4 | |a RA8.A247 |b W46 2003 | |
110 | 2 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations. |b Meeting |n (37th : |d 2001 : |c Geneva, Switzerland) | |
245 | 1 | 0 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations |h [electronic resource] : |b thirty-seventh report. |
260 | |a Geneva : |b World Health Organization, |c 2003. | ||
300 | |a viii, 145 p. | ||
490 | 1 | |a WHO technical report series, |x 0512-3054 ; |v 908 | |
505 | 0 | |a 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals. | |
533 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
650 | 0 | |a Drugs |x Standards |v Congresses. | |
650 | 0 | |a Drugs |x Specifications |v Congresses. | |
650 | 0 | |a Pharmaceutical industry |x Quality control |v Congresses. | |
655 | 4 | |a Electronic books. | |
710 | 2 | |a ProQuest (Firm) | |
830 | 0 | |a Technical report series (World Health Organization) ; |v 908. | |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793 |z Click to View |